Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  NuPathe Inc    PATH

 SummaryQuotesNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
03/28Earnings Release
More about the company
Latest news on NUPATHE INC
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2013 NUPATHE INC : Program Participations and Positive Stock Movements - Research Rep..
2013 NUPATHE INC : NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investi..
2013 NUPATHE INC : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NU..
2013 NUPATHE INC : Harwood Feffer LLP Announces Investigation of NuPathe, Inc.
2013 NUPATHE INC : PATH SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter is Investi..
2013 NUPATHE INC : SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces In..
More news
Sector news : Pharmaceuticals - NEC
08:40aDJASTRAZENECA : Sets New Deadlines for MYSTIC Trial
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/13DJLONDON MARKETS : FTSE 100 Continues Record Run, Rising For 14th Day In A Row
01/13 FTSE hits record highs, extends historic winning streak
01/12DJCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- Update
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Richard S. Egosi President, Chief Executive Officer & Director
Deborah A. Griffin Chief Financial Officer, Treasurer, Director & VP
Mark W. Pierce Chief Scientific Officer & Vice President
Austin D. Kim Secretary
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NUPATHE INC0.00%0
JOHNSON & JOHNSON-0.53%311 773
ROCHE HOLDING LTD.2.75%203 077
PFIZER INC.0.12%197 343
NOVARTIS AG-1.48%187 856
MERCK & CO., INC.5.89%171 880
More Results